- Home
- SUPN vs PAX Comparison
SUPN vs PAX Comparison
Compare SUPN & PAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- PAX
- Stock Information
- Founded
- SUPN 2005
- PAX 1988
- Country
- SUPN United States
- PAX Cayman Islands
- Employees
- SUPN N/A
- PAX N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- PAX Investment Managers
- Sector
- SUPN Health Care
- PAX Finance
- Exchange
- SUPN Nasdaq
- PAX Nasdaq
- Market Cap
- SUPN 2.6B
- PAX 2.2B
- IPO Year
- SUPN 2012
- PAX 2021
- Fundamental
- Price
- SUPN $46.21
- PAX $14.19
- Analyst Decision
- SUPN Buy
- PAX Strong Buy
- Analyst Count
- SUPN 2
- PAX 1
- Target Price
- SUPN $43.00
- PAX $14.00
- AVG Volume (30 Days)
- SUPN 707.2K
- PAX 533.5K
- Earning Date
- SUPN 11-03-2025
- PAX 11-04-2025
- Dividend Yield
- SUPN N/A
- PAX 6.16%
- EPS Growth
- SUPN 1411.53
- PAX N/A
- EPS
- SUPN 1.14
- PAX 0.53
- Revenue
- SUPN $665,125,000.00
- PAX $397,504,000.00
- Revenue This Year
- SUPN $4.84
- PAX N/A
- Revenue Next Year
- SUPN $17.69
- PAX $22.27
- P/E Ratio
- SUPN $40.24
- PAX $26.90
- Revenue Growth
- SUPN 5.55
- PAX 26.52
- 52 Week Low
- SUPN $29.16
- PAX $9.43
- 52 Week High
- SUPN $46.79
- PAX $14.52
- Technical
- Relative Strength Index (RSI)
- SUPN 73.71
- PAX 65.42
- Support Level
- SUPN $44.10
- PAX $13.29
- Resistance Level
- SUPN $46.79
- PAX $14.14
- Average True Range (ATR)
- SUPN 1.06
- PAX 0.29
- MACD
- SUPN -0.17
- PAX 0.09
- Stochastic Oscillator
- SUPN 85.92
- PAX 88.28
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About PAX Patria Investments Limited
Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.